Infiltrating Treg and Th17 Cells of the Prostate Hypertrophy Gland Associated with Propionibacterium Acnes Infection
Authors Radej S, Płaza P, Olender A, Szewc M, Bar K, Maciejewski R
Received 29 September 2020
Accepted for publication 9 November 2020
Published 30 November 2020 Volume 2020:12 Pages 593—597
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jan Colli
Sebastian Radej,1 Paweł Płaza,2 Alina Olender,3 Monika Szewc,1 Krzysztof Bar,2 Ryszard Maciejewski1
1Department of Normal Anatomy, Medical University of Lublin, Lublin, Poland; 2Urology and Urological Oncology, Medical University of Lublin, Lublin, Poland; 3Chair and Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland
Correspondence: Sebastian Radej
Department of Normal Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090, Lublin, Poland
Tel/Fax +4881448 6020
Purpose: The aim of the study was to evaluate prostate cell infiltration by CD4(+)IL-17(+) and Treg cells in BPH and PCa patients depending on P. acnes infection in the prostate gland.
Patients and Methods: Prostate fragments were collected from 54 patients with PCa and 34 patients with BPH. Rapid ID 32 was used to identify the bacteria. Cells were analyzed by flow cytometry BD FACSCanto II. Statistical analysis was performed using Statistica 7 software (TIBCO Software Inc, USA).
Results: P. acnes was detected in 35% of patients with PCa and 41% of individuals with BPH. The infiltration of CD4(+)IL-17(+) and Treg cells was statistically significantly higher (P = 0.001) in patients with BPH and positive for P. acnes. A statistically considerably higher (P = 0.001) infiltration of Treg cells in treated for PCa with P.acnes infection was also demonstrated.
Conclusion: Prostatitis caused by P. acnes may contribute to the development of BPH and PCa.
Keywords: P. acnes, Treg cells, Th17 cells, benign prostatic hyperplasia, prostate cancer
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]